Shares of Plexus Corp. (NASDAQ:PLXS) have been assigned a consensus rating of “Hold” from the eleven research firms that are covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $59.17.

PLXS has been the subject of several research reports. Longbow Research raised Plexus from a “neutral” rating to a “buy” rating in a report on Monday, January 8th. ValuEngine raised Plexus from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. TheStreet downgraded Plexus from an “a-” rating to a “c+” rating in a report on Wednesday, January 17th. Citigroup boosted their target price on Plexus from $59.00 to $65.00 and gave the company a “neutral” rating in a report on Friday, October 27th. Finally, JPMorgan Chase & Co. downgraded Plexus from an “overweight” rating to a “neutral” rating and set a $62.00 target price for the company. in a report on Tuesday, October 10th.

In related news, Director Peter Kelly acquired 5,000 shares of Plexus stock in a transaction on Wednesday, January 24th. The stock was purchased at an average cost of $60.00 per share, with a total value of $300,000.00. Following the purchase, the director now directly owns 21,896 shares in the company, valued at $1,313,760. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Dean A. Foate sold 23,950 shares of the company’s stock in a transaction that occurred on Wednesday, November 22nd. The shares were sold at an average price of $63.08, for a total value of $1,510,766.00. Following the sale, the chairman now directly owns 293,370 shares of the company’s stock, valued at $18,505,779.60. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 122,238 shares of company stock valued at $7,585,035. 3.70% of the stock is owned by company insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in Plexus by 1.7% during the 2nd quarter. Vanguard Group Inc. now owns 3,310,813 shares of the technology company’s stock valued at $174,049,000 after acquiring an additional 53,925 shares during the last quarter. Disciplined Growth Investors Inc. MN increased its position in Plexus by 0.5% during the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 3,038,867 shares of the technology company’s stock worth $159,753,000 after purchasing an additional 16,329 shares during the period. Dimensional Fund Advisors LP increased its position in Plexus by 0.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,832,718 shares of the technology company’s stock worth $158,859,000 after purchasing an additional 15,581 shares during the period. FMR LLC increased its position in Plexus by 546.1% during the 2nd quarter. FMR LLC now owns 1,111,655 shares of the technology company’s stock worth $58,440,000 after purchasing an additional 939,589 shares during the period. Finally, Northern Trust Corp increased its position in Plexus by 2.2% during the 2nd quarter. Northern Trust Corp now owns 1,034,130 shares of the technology company’s stock worth $54,363,000 after purchasing an additional 22,477 shares during the period. 93.93% of the stock is owned by hedge funds and other institutional investors.

Shares of Plexus (NASDAQ PLXS) traded down $0.20 during midday trading on Friday, reaching $59.75. The company’s stock had a trading volume of 121,103 shares, compared to its average volume of 180,914. Plexus has a 12 month low of $49.06 and a 12 month high of $66.78. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.90 and a quick ratio of 1.08. The stock has a market cap of $2,020.00, a P/E ratio of -117.16 and a beta of 0.88.

Plexus (NASDAQ:PLXS) last posted its earnings results on Wednesday, January 17th. The technology company reported $0.75 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.80 by ($0.05). Plexus had a negative net margin of 0.57% and a positive return on equity of 11.24%. The firm had revenue of $677.00 million during the quarter, compared to analysts’ expectations of $685.07 million. During the same period in the previous year, the firm posted $0.82 earnings per share. The firm’s revenue for the quarter was up 6.6% on a year-over-year basis. equities analysts anticipate that Plexus will post 3.25 earnings per share for the current year.

WARNING: “Brokerages Set Plexus Corp. (PLXS) PT at $59.17” was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another website, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this article can be viewed at https://www.dailypolitical.com/2018/01/31/brokerages-set-plexus-corp-plxs-pt-at-59-17.html.

Plexus Company Profile

Plexus Corp. (Plexus) and its subsidiaries are engaged in the electronic manufacturing services (EMS) industry. The Company delivers end-to-end solutions for customers in the Americas (AMER), Europe, Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions. The Company’s segments are AMER, APAC and EMEA.

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.